Debt-to-equity of Edwards Lifesciences Corp from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Edwards Lifesciences Corp quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Edwards Lifesciences Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 29%, a 21% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Edwards Lifesciences Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 29% -7% -21% 30 Sep 2025
Q2 2025 30% -7% -20% 30 Jun 2025
Q1 2025 32% -7% -18% 31 Mar 2025
Q4 2024 34% -7% -17% 31 Dec 2024
Q3 2024 36% -5% -12% 30 Sep 2024
Q2 2024 37% -4% -9.2% 30 Jun 2024
Q1 2024 39% -3% -6.9% 31 Mar 2024
Q4 2023 41% -1% -2.8% 31 Dec 2023
Q3 2023 41% -1% -2.7% 30 Sep 2023
Q2 2023 41% -3% -7.6% 30 Jun 2023
Q1 2023 42% 31 Mar 2023
Q4 2022 42% 31 Dec 2022
Q3 2022 43% 30 Sep 2022
Q2 2022 45% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.